Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-24-017373

CEO gave up 215,991 shares (to pay taxes)

  • CEO acquired 390,579 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gline Matthew CEO 2024-03-30 Option exercise 10b5-1 +390,579 1,380,642 D: show line 1 in the form
Gline Matthew CEO 2024-03-30 Shares withheld for taxes 10b5-1 −215,991 $10.54 $2,276,545 1,164,651 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gline Matthew CEO 2024-03-30 Option exercise · Capped Value Appreciation Rights 10b5-1 −994,373 $6.40 $6,363,987 0 D: show line 3 in the form
Loading xslF345X05/form4.xml…